- Even as penny stocks are known to be highly volatile and involve considerable risks, these are still widely traded.
- Several experienced investors and traders have earned significant profits out of such stocks.
- Province Resources, Oneview Healthcare and Doriemus are a few penny stocks whose stock prices have more than doubled so far in 2021.
Even as penny stocks are known to be highly volatile and involve considerable risks, these are still widely traded. The reason for their popularity among small investors is their ability to surprise with significant returns. However, there are always equal changes that investors may burn their fingers while investing in penny stocks.
Several experienced investors and traders have earned significant profits out of such stocks. Province Resources, Oneview Healthcare, and Doriemus are a few penny stocks whose stock prices have more than doubled so far in 2021.
Here are 10 penny stocks that have more than doubled this year. The stocks have been ranked in a descending order.
Source: © Herrbullermann | Megapixl.com
Province Resources (ASX:PRL)
The oil & gas company has had a splendid year so far, with its shares generating an excellent YTD return of 1,270%. On 15 June 2021, the Company recruited two key management personnel Greg Walker and Burke Maslen to drive approvals and key stakeholder engagement. The company also aims to take advantage of a booming green energy market.
Oneview Healthcare PLC (ASX:ONE)
Established in 2012, Oneview Healthcare provides a software platform to healthcare organisations and patients for improved clinical outcomes. The shares have given a return of 630% year to date to the shareholders. The company last month inked a five-year agreement with Northern Health, in Melbourne’s strong-growing northern growth corridor, as its initial Cloud Start client in Australia.
Actinogen Medical Ltd (ASX:ACW)
The biotech firm develops an innovative treatment for cognitive impairment linked with neurological diseases open to changes of raised cortisol levels within brain cells. The shares have given a YTD return of 450%. Last month, the company received a written supportive US FDA advice in response to its Pre-Investigational New Drug Application submission for its FXS program.
Doriemus Plc (ASX:DOR)
The company deals in the oil and gas exploration and production under the energy sector. Doriemus gave a robust YTD return of 400%. On 8 June 2021, Doriemus announced the capital raising of nearly AU$3,340,000. The proceeds from the capital raise would be used for enhancing its oil and gas assets in the UK and Europe.
Source: ©Miflippo | Megapixl.com
Aquis Entertainment Ltd (ASX:AQS)
Aquis Entertainment is a gaming and entertainment company. Its shares have delivered a YTD return of 400%.
Queensland Pacific Metals Ltd (ASX:QPM)
The company is engaged in exploring and developing battery chemicals, including nickel sulphate, alumina, and cobalt sulphate. The shares have given a return of 262.505% so far this year. The company last month inked binding offtake deals for Ni and Co offtake from the TECH Project with LGES and POSCO.
Globe Metals & Mining Ltd (ASX:GBE)
Globe Metals & Mining an African-focused resources company having Kanyika niobium project in Malawi. Its shares have delivered a YTD return of 237.50%.
Source: ©Ymgerman | Megapixl.com
Carpentaria Resources Ltd (ASX:CAP)
Carpentaria is a mineral exploration firm. It develops its flagship Hawsons Iron Project near Broken Hill, NSW. Carpentaria Resources’ shares delivered a YTD return of 224%.
Piedmont Lithium Ltd (ASX:PLL)
Incorporated in 1983, Piedmont Lithium conducts exploration and development of minerals. The shares of the company are up 137.84% up to date. The stock is up after the lithium company signed a binding sales agreement with electric vehicles giant Tesla in September. Even positive outlook around lithium demand for batteries has supported the share price.
Anteotech Ltd (ASX:ADO)
Anteotech is a company listed in 2000 under the industry group of Pharmaceuticals, Biotechnology & Life Sciences. The company was involved in developing and commercialising medical products under the healthcare sector. The Anteotech share price has been rocketing higher in 2021 and is up 109.09% since the turn of the year. The shares have risen ever since its customer Ellume’s COVID-19 test received the first at-home test to gain US FDA emergency approval.
(Investors are advised to be vigilant with penny stocks since these involve heavy risks.)
READ MORE: Which are the top 5 ASX 200 dividend shares?